AVE Science&TechnologyLTD Valuation

Is 688067 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 688067 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 688067 (CN¥17.97) is trading above our estimate of fair value (CN¥1.11)

Significantly Below Fair Value: 688067 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 688067?

Key metric: As 688067 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 688067. This is calculated by dividing 688067's market cap by their current earnings.
What is 688067's PE Ratio?
PE Ratio	53.7x
Earnings	CN¥22.56m
Market Cap	CN¥1.21b

688067 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	5.8x
Enterprise Value/EBITDA	48.9x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 688067's PE Ratio compare to its peers?

The above table shows the PE ratio for 688067 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	42.5x
688607 CareRay Digital Medical Technology	53.1x	34.4%	CN¥1.3b
688393 Guangzhou LBP Medicine Science & Technology	58.9x	n/a	CN¥1.9b
301290 Jiangsu Canopus Wisdom Medical TechnologyLtd	27.9x	n/a	CN¥2.6b
301515 Sichuan Gangtong Medical Equipment Group	30.3x	n/a	CN¥2.0b
688067 AVE Science&TechnologyLTD	53.7x	n/a	CN¥1.2b

Price-To-Earnings vs Peers: 688067 is expensive based on its Price-To-Earnings Ratio (53.7x) compared to the peer average (42.5x).

Price to Earnings Ratio vs Industry

How does 688067's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 688067 is expensive based on its Price-To-Earnings Ratio (53.7x) compared to the CN Medical Equipment industry average (35.3x).

Price to Earnings Ratio vs Fair Ratio

What is 688067's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

688067 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	53.7x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 688067's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Shandong Pharmaceutical GlassLtd

CN¥17.0b

Manufactures and sells pharmaceutical glass packaging and butyl rubber series products in China.

600529

CN¥25.63

-1.1%

-1.8%

Shenzhen Mindray Bio-Medical Electronics

CN¥327.4b

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

300760

CN¥270.68

-4.8%

-5.2%

Shenzhen Lifotronic Technology

CN¥7.1b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥16.49

-3.7%

-28.0%